文章:
癌症的信号转导及转录激活因子(STAT)家族蛋白——新的分子靶点成熟
The STATs of cancer —— new molecular targets come of age
原文发布日期:2004-02-01
DOI: 10.1038/nrc1275
类型: Review Article
开放获取: 否
要点:
- Signal transducer and activator of transcription (STAT)-family proteins are latent cytoplasmic transcription factors that convey signals from cytokine and growth-factor receptors to the nucleus.
- STAT proteins, particularly STAT3 and the STAT5 proteins, are frequently overactivated in a variety of human solid tumours and blood malignancies.
- Continuous deregulation of nuclear gene expression by persistent STAT3 and STAT5 signalling promotes the growth and survival of tumour cells, thereby contributing to malignancy.
- Persistent STAT3 signalling in tumour cells induces tumour angiogenesis and suppresses anti-tumour immune responses, further enhancing tumour progression.
- Tumour cells that become dependent on persistent STAT3 signalling are more sensitive to STAT3 inhibitors than normal cells, providing a therapeutic window based on transient or partial inhibition of STAT3.
- Proof-of-concept studies in cell-culture and animal models have validated STAT3 and STAT5 proteins as promising molecular targets for novel cancer therapies, including small-molecule inhibitors of STAT signalling.
要点翻译:
- 信号转导及转录激活因子(STAT)家族蛋白是潜伏在细胞质中的转录因子,它们将细胞因子和生长因子受体的信号传递至细胞核。
- STAT蛋白,特别是STAT3和STAT5蛋白,在多种人类实体瘤和血液恶性肿瘤中频繁过度激活。
- 持续的STAT3和STAT5信号通路通过不断扰乱核内基因表达,促进肿瘤细胞的生长和存活,从而加剧恶性病变。
- 肿瘤细胞中持续的STAT3信号会诱导肿瘤血管生成并抑制抗肿瘤免疫反应,进一步推动肿瘤进展。
- 对持续STAT3信号产生依赖的肿瘤细胞相比正常细胞对STAT3抑制剂更为敏感,这为基于短暂或部分抑制STAT3的治疗策略提供了治疗窗口。
- 在细胞培养和动物模型中开展的概念验证研究已确认STAT3和STAT5蛋白是新型癌症疗法(包括STAT信号通路的小分子抑制剂)极具前景的分子靶点。
英文摘要:
Tumour cells acquire the ability to proliferate uncontrollably, resist apoptosis, sustain angiogenesis and evade immune surveillance. STAT proteins — especially STAT3 and STAT5 — regulate all of these processes and are persistently activated in a surprisingly large number of human cancers. Consequently, STAT proteins are emerging — unexpectedly — as ideal targets for cancer therapy.
摘要翻译:
肿瘤细胞获得失控增殖、抵抗凋亡、维持血管生成以及逃避免疫监视的能力。STAT蛋白——尤其是STAT3和STAT5——调控所有这些过程,并在数量惊人的人类癌症中持续激活。因此,STAT蛋白正出乎意料地成为癌症治疗的理想靶点。
原文链接:
The STATs of cancer — new molecular targets come of age